NIAID supports the study of global research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases and conditions. In addition to advancing these scientific goals, NIAID global research helps to improve the health of millions of people around the world, to protect the United States against infectious disease threats, and to promote international economic and political stability. Together, these efforts establish NIAID as a leader in global health.
Media Availability: NIH Study Supports Camels as Primary Source of MERS-CoV Transmission—Sept. 24, 2014
Media Availability: Rapid and Durable Protection Against Ebola Virus With New Vaccine Regimens—Sept. 7, 2014
Media Availability: NIH-Led Scientists Discover HIV Antibody that Binds to Novel Target on Virus—Sept. 3, 2014
NIH to Launch Human Safety Study of Ebola Vaccine Candidate—Aug. 28, 2014
All Global Research News Releases
News From NIAID-Supported Institutions
Last Updated September 25, 2014